Tresiba
Insulin Degludec · Novo Nordisk
Tresiba (insulin degludec) is an ultra-long-acting insulin lasting up to 42 hours, allowing more flexible dosing times. It has a lower risk of nighttime low blood sugar compared to other long-acting insulins.
FDA-Approved Uses
Tresiba is FDA-approved for the following conditions.
Dosing: Once daily, flexible timing
Average Cost
What you can expect to pay for Tresiba.
Need help affording Tresiba?
Answer 9 questions. See every program you're eligible for. Free.
Medicaid Coverage by State
Tresiba coverage status across all 51 states and territories.
| State | Medicaid | Medicare | Prior Auth |
|---|---|---|---|
| Alabama | Covered | Covered | No |
| Alaska | Covered | Covered | No |
| Arizona | Covered | Covered | No |
| Arkansas | Covered | Covered | No |
| California | Covered | Covered | No |
| Colorado | Covered | Covered | No |
| Connecticut | Covered | Covered | No |
| Delaware | Covered | Covered | No |
| District of Columbia | Covered | Covered | No |
| Florida | Covered | Covered | No |
| Georgia | Covered | Covered | No |
| Hawaii | Covered | Covered | No |
| Idaho | Covered | Covered | No |
| Illinois | Covered | Covered | No |
| Indiana | Covered | Covered | No |
| Iowa | Covered | Covered | No |
| Kansas | Covered | Covered | No |
| Kentucky | Covered | Covered | No |
| Louisiana | Covered | Covered | No |
| Maine | Covered | Covered | No |
| Maryland | Covered | Covered | No |
| Massachusetts | Covered | Covered | No |
| Michigan | Covered | Covered | No |
| Minnesota | Covered | Covered | No |
| Mississippi | Covered | Covered | No |
| Missouri | Covered | Covered | No |
| Montana | Covered | Covered | No |
| Nebraska | Covered | Covered | No |
| Nevada | Covered | Covered | No |
| New Hampshire | Covered | Covered | No |
| New Jersey | Covered | Covered | No |
| New Mexico | Covered | Covered | No |
| New York | Covered | Covered | No |
| North Carolina | Covered | Covered | No |
| North Dakota | Covered | Covered | No |
| Ohio | Covered | Covered | No |
| Oklahoma | Covered | Covered | No |
| Oregon | Covered | Covered | No |
| Pennsylvania | Covered | Covered | No |
| Rhode Island | Covered | Covered | No |
| South Carolina | Covered | Covered | No |
| South Dakota | Covered | Covered | No |
| Tennessee | Covered | Covered | No |
| Texas | Covered | Covered | No |
| Utah | Covered | Covered | No |
| Vermont | Covered | Covered | No |
| Virginia | Covered | Covered | No |
| Washington | Covered | Covered | No |
| West Virginia | Covered | Covered | No |
| Wisconsin | Covered | Covered | No |
| Wyoming | Covered | Covered | No |
Patient Assistance Programs
Novo Nordisk offers savings programs that may reduce your cost to $0. Check eligibility below.
Check Eligibility at Novo Nordisk ↗Tresiba Side Effects
Common and serious side effects to discuss with your doctor.
⚡ Common Side Effects
- Injection site reactionscommon
- Weight gaincommon
⚠️ Serious Side Effects
- Low blood sugarcommon
- Allergic reactionsrare
Seek immediate medical attention if you experience any serious side effects.
Frequently Asked Questions
How much does Tresiba cost without insurance?
Tresiba costs approximately $380 per month without insurance. With insurance, copays range from $15 to $100 per month.
Does Medicaid cover Tresiba?
Medicaid coverage for Tresiba varies by state. Many states cover it with prior authorization. See the coverage table below for your state.
What are the side effects of Tresiba?
Common side effects include injection site reactions, weight gain. Serious but rare side effects include low blood sugar and allergic reactions.
What is the generic name for Tresiba?
The generic name for Tresiba is Insulin Degludec. It is manufactured by Novo Nordisk.
Get Your Free Benefits Report
Enter your email to receive a personalized report of every benefit program you may qualify for.
No spam. Unsubscribe anytime.